Introduction Psychedelic-assisted therapy shows promise for treating various mental health conditions; however, its reliance on intensive psychological preparation limits its broader application.

Multiple legacy media has reported on a newly surfaced intelligence memo warning that Iran may have considered launching drone attacks toward California. The news stirred debate across security ...

G&A Expenses -- $13.8 million in the fourth quarter, of which $5.6 million was non-cash stock-based compensation; annual G&A ...

Allogene Therapeutics, Inc. (NASDAQ:ALLO) Q4 2025 Earnings Call Transcript March 12, 2026 Allogene Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.17, expectations were $-0.22551.

The S&P/ASX 200 is set to open lower as oil prices closed at the highest since August 2022. Here are today's top stories.

A comparative evaluation indicates that climate anomalies over the past three years have been particularly severe. The rise in temperatures in certain regions, alongside unprecedented climate ...

Investopedia contributors come from a range of backgrounds, and over 25 years there have been thousands of expert writers and editors who have contributed. Gordon Scott has been an active investor and ...